Pharma - Industry – Focus

 

Custom Search

Matrix Laboratories is expanding its bulk drug unit capacity at Jeedimetla plant

 

Matrix Laboratories is expanding its capacity of bulk drug unit from 27.1 tpm to 69.0 tpm at Jeedimetla in Ranga Reddy district of Andhra Pradesh with an investment of Rs. 12 million. The company is expanding its production with the following

S.N.

Product

Quantity (TPM)

Remarks

Existing

Proposed

1.       

Ciprofloxacin

8.0

20.0

Existing Products; Capacity enhanced

2.       

Norfloxacin

3.3

4.7

Existing Products; Capacity enhanced

3.       

Citalapram

1.3

4.0

Existing Products; Capacity enhanced

4.       

Mirtazapine

0.2

0.6

Existing Products; Capacity enhanced

5.       

Valsartan

0.3

1.0

Existing Products; Capacity enhanced

6.       

Modafinil

--

0.5

To be included in new product mix.

7.       

Simvastatin

1.5

7.2

Existing Products; Capacity enhanced

8.       

Gatifloxacin

3.0

3.0

Existing Products; No change in Capacity

9.       

Gabapentine

5.0

5.0

Existing Products; No change in Capacity

10.   

Risperidone

1.0

Nil

Dropped the product

11.   

Levofloxacin

1.0

3.9

Existing Products; Capacity enhanced

12.   

Carvedilol

-

0.5

To be included in new product mix.

13.   

Moxifloxacin

1.5

2.7

Existing Products; Capacity enhanced

14.   

Sertraline HCL

--

13.5

New Product

15.   

Duloxetine

--

1.9

New Product

Total

27.1

69.0

 

 

Custom Search

Copyright © 2013 Ibis Research Information Services Pvt Ltd. All Rights Reserved.
Contact : Ibis Research Information Services Pvt Ltd., 28, Rajaji Street, NGO Colony
Guduvancherry, Chennai -603 202   Mobile : 0-97898-37940 email : ibischennai@gmail.com Privacy Policy